AU$12 million in 'R&D Start' grants

Tuesday, 30 August, 2005

A handheld biosensor device that can immediately register food, water and blood contaminants will be developed with the help of a AU$774,000 Australian government grant, as part of a multi-million dollar R&D Start funding round recently announced by Federal Minister for Industry, Tourism & Resources, Ian Macfarlane.

Mr Macfarlane announced Queensland innovators Cleveland Biosensors as one of seven companies to receive grants totalling more than AU$12 million under the latest round of the business innovation program.

"This product, when commercialised, will provide significant benefits in food safety, biosecurity and personalised medicine - particularly where the long wait for laboratory results puts individuals and communities at risk," Mr Macfarlane said. Other companies to receive R&D Start grants include:

  • Cutting Edge Post, of South Brisbane, awarded AU$990,752 for its self-contained digital post-production system for television program production. It is particularly suited to managing lengthy footage from reality shows where time to air is very short and content requires speedy analysis.
  • Iliad Chemicals Pty Ltd, of Bundoora, awarded AU$636,462 to develop vascular targeting agents, using Iliad's MultiCore technology, as a new validated approach for the treatment of cancer.
  • Locata Corporation, of the ACT, awarded AU$4,930,000 for its antenna system for indoor positioning applications. The company will develop an advanced form of its radio-positioning technology for the warehouse and industrial automation markets.

Since 1996, R&D Start has delivered funding of more than AU$1.4 billion to innovative Australian companies. Its successor program, Commercial Ready, is now open for business, providing up to AU$200 million a year to support business R&D, proof-of-concept, and early-stage commercialisation activities.

Related News

Applications now open for Scopus Researcher Awards

The Scopus Researcher Awards recognise outstanding researchers in Australia and New Zealand who...

AdAlta appoints new CEO, secures licensing deal

The Melbourne drug development company has announced Dr Tim Oldham as its new CEO and signed a...

2019 Nobel Prize winners announced

The 2019 Nobel Prizes acknowledge scientists whose discoveries have opened up possibilities for...

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd